HomeAboutRankingsData Sources
© 2026 GeneE
🧬
GeneE
6 sources retrieved · Most recent: April 2026 · Index updated 14 days ago
ⓘGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
SLC35F5
solute carrier family 35 member F5
Chromosome 2 · 2q14.1
NCBI Gene: 80255Ensembl: ENSG00000115084.15HGNC: HGNC:23617UniProt: B8ZZV6
15PubMed Papers
20Diseases
0Drugs
0Pathogenic Variants
FUNCTIONAL ROLE
Transporter
DATA QUALITY
✓ Experimental GO Evidence✓ Swiss-Prot Reviewed
choline transmembrane transporter activitycholine transportmembraneplacenta praeviaisolated hyperchlorhidrosishypoparathyroidism, familial isolated, 2Hearing loss - familial salivary gland insensitivity to aldosterone
✦AI Summary

SLC35F5 is a solute carrier family member with primary function as a choline transporter 1. The protein demonstrates significant organic cation transport activity, with particular emphasis on choline uptake 1. Mechanistically, computational modeling and gene ontology analysis suggest SLC35F5 likely localizes to the Golgi apparatus and functions as an importer of flavin adenine dinucleotide (FAD), with predicted substrate affinity of 0.1-0.4 nM 2. This FAD import function is proposed to support disulfide-bond formation during post-translational modification of secretory proteins 2. SLC35F5 displays ubiquitous mRNA expression across adult and fetal tissues 3, suggesting broad physiological relevance. Clinically, SLC35F5 has been implicated in chemoresistance, where miR-369-3p-mediated downregulation of SLC35F5 sensitizes non-small cell lung cancer cells to cisplatin through disruption of nucleotide sugar transportation 4. Additionally, SLC35F5 expression levels predict 5-fluorouracil chemosensitivity in colorectal cancer, where it functions as part of a three-gene response index for predicting chemotherapy efficacy 5. SLC35F5 has been identified as a candidate disease gene in Mendelian disorders affecting neurocognitive development 6.

Sources cited
1
SLC35F5 localizes to Golgi apparatus and imports FAD with predicted affinity of 0.1-0.4 nM to support disulfide-bond formation
PMID: 41516385
2
SLC35F5 functions as an organic cation transporter with significant choline uptake activity
PMID: 39098524
3
miR-369-3p regulates SLC35F5 to modulate cisplatin chemoresistance in non-small cell lung cancer through nucleotide sugar transport disruption
PMID: 28511796
4
SLC35F5 mRNA expression is ubiquitous across adult and fetal tissues
PMID: 19252338
5
SLC35F5 expression levels predict 5-fluorouracil chemosensitivity in colorectal cancer as part of a response prediction index
PMID: 16477629
6
SLC35F5 identified as a candidate disease gene in Mendelian neurocognitive disorders
PMID: 26077850
Disease Associationsⓘ20
placenta praeviaOpen Targets
0.18Weak
isolated hyperchlorhidrosisOpen Targets
0.04Suggestive
hypoparathyroidism, familial isolated, 2Open Targets
0.04Suggestive
Hearing loss - familial salivary gland insensitivity to aldosteroneOpen Targets
0.04Suggestive
hearing loss-familial salivary gland insensitivity to aldosterone syndromeOpen Targets
0.04Suggestive
intestinal hypomagnesemia 1Open Targets
0.04Suggestive
Primary hypomagnesemia with secondary hypocalcemiaOpen Targets
0.04Suggestive
tricuspid valve diseaseOpen Targets
0.04Suggestive
corneal ulcerOpen Targets
0.03Suggestive
malunion fractureOpen Targets
0.03Suggestive
alcohol drinkingOpen Targets
0.02Suggestive
hypertrophic cardiomyopathyOpen Targets
0.02Suggestive
Leber congenital amaurosisOpen Targets
0.01Suggestive
chronic kidney diseaseOpen Targets
0.01Suggestive
juvenile dermatomyositisOpen Targets
0.01Suggestive
colorectal carcinomaOpen Targets
0.01Suggestive
Alzheimer diseaseOpen Targets
0.00Suggestive
Pick diseaseOpen Targets
0.00Suggestive
IGA glomerulonephritisOpen Targets
0.00Suggestive
acute quadriplegic myopathyOpen Targets
0.00Suggestive
Pathogenic Variants
No pathogenic variants reported on ClinVar for this gene.
View on ClinVar ↗
Related Genes
SLC35F2Shared pathway100%SLC35G4Shared pathway100%SLC35F3Shared pathway100%SLC35F4Shared pathway76%SLC25A48Shared pathway50%FLVCR2Shared pathway50%
Tissue Expression6 tissues
Heart
100%
Liver
51%
Ovary
47%
Lung
38%
Bone Marrow
29%
Brain
25%
Gene Interaction Network
Click a node to explore
SLC35F5SLC35F2SLC35G4SLC35F3SLC35F4SLC25A48FLVCR2
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted · UniProt Q8WV83
View on AlphaFold ↗
Constraintⓘ
LOEUFⓘ
1.16LoF Tolerant
pLIⓘ
0.00Tolerant
Observed/Expected LoF0.86 [0.64–1.16]
RankingsWhere SLC35F5 stands among ~20K protein-coding genes
  • #15,690of 20,598
    Most Researched15
  • #12,113of 17,882
    Most Constrained (LOEUF)1.16
Genes detectedSLC35F5
Sources retrieved6 papers
Response time—
📄 Sources
6▼
1
Molecular Modeling and Gene Ontology Implicate SLC35F4 and SLC35F5 as Golgi-Associated Importers of Flavin-Adenine-Dinucleotide.
PMID: 41516385
Int J Mol Sci · 2026
1.00
2
Several orphan solute carriers functionally identified as organic cation transporters: Substrates specificity compared with known cation transporters.
PMID: 39098524
J Biol Chem · 2024
0.83
3
Attenuation of deregulated miR-369-3p expression sensitizes non-small cell lung cancer cells to cisplatin via modulation of the nucleotide sugar transporter SLC35F5.
PMID: 28511796
Biochem Biophys Res Commun · 2017
0.67
4
High diagnostic yield of clinical exome sequencing in Middle Eastern patients with Mendelian disorders.
PMID: 26077850
Hum Genet · 2015
0.50
5
Predicting 5-fluorouracil chemosensitivity of liver metastases from colorectal cancer using primary tumor specimens: three-gene expression model predicts clinical response.
PMID: 16477629
Int J Cancer · 2006
0.33